Titlebook: Nisoldipine Coat-Core; Michel F. Rousseau Conference proceedings 1999 Springer-Verlag Berlin Heidelberg 1999 Beta-Blocker.Herzkrankheit.Ko

digestive-tract

書(shū)目名稱(chēng)Nisoldipine Coat-Core影響因子(影響力)




書(shū)目名稱(chēng)Nisoldipine Coat-Core影響因子(影響力)學(xué)科排名




書(shū)目名稱(chēng)Nisoldipine Coat-Core網(wǎng)絡(luò)公開(kāi)度




書(shū)目名稱(chēng)Nisoldipine Coat-Core網(wǎng)絡(luò)公開(kāi)度學(xué)科排名




書(shū)目名稱(chēng)Nisoldipine Coat-Core被引頻次




書(shū)目名稱(chēng)Nisoldipine Coat-Core被引頻次學(xué)科排名




書(shū)目名稱(chēng)Nisoldipine Coat-Core年度引用




書(shū)目名稱(chēng)Nisoldipine Coat-Core年度引用學(xué)科排名




書(shū)目名稱(chēng)Nisoldipine Coat-Core讀者反饋




書(shū)目名稱(chēng)Nisoldipine Coat-Core讀者反饋學(xué)科排名

cogent

Jejune

custody

Michel F. RousseauIncludes supplementary material:

背信

http://image.papertrans.cn/n/image/666617.jpg

哥哥噴涌而出

CLOUT

,The Coronary Selectivity of Calcium Antagonists — Focus on CHD,kers (CCBs), also termed calcium antagonists, calcium entry blockers or more simply calcium blockers (in French, anticalciques), inhibit the inward movement of calcium in depolarised muscles. This calcium influx occurs through L-type (long-lasting, large-current, or slow), voltage-dependent calcium

JOT

小丑

,Viable Myocardium — the Place of Calcium Antagonists,ial infarction, may be reversible or permanent [1]. Thrombolytic therapy increases the probability of early reperfusion and may increase the probability of reversible dysfunction [2]. The infarcted segments may show resting hypoperfusion, despite a preserved viability, and functional recovery once p

Digest

Hemodynamic and Cardiac Effects of Nisoldipine in Ischemic Left Ventricular Dysfunction,ohormonal activation and of worsening of congestive heart failure symptoms during their administration [1–5]. However, the negative results observed with some calcium antagonists such as nifedipine or diltiazem [4, 5] are balanced by more promising observations with amlodipine and nisoldipine [6, 7]